Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220808712> ?p ?o ?g. }
- W4220808712 endingPage "15" @default.
- W4220808712 startingPage "1" @default.
- W4220808712 abstract "Gynostemma pentaphyllum (Thunb.) Makino (G. pentaphyllum) is a natural herbal drug that has been widely used to treat many diseases. The antitumor effects of G. pentaphyllum were first described in the illustrated catalog of plants. Gypenosides are the major active components of G. pentaphyllum, and they have been widely reported to possess antitumor effects in prostate cancer, gastric cancer, hepatocellular carcinoma, colon cancer, lung cancer, and breast cancer. However, research on the use of gypenoside in the treatment of bladder cancer has not been conducted. In this study, we explored the potential molecular mechanisms of gypenosides in the treatment of bladder cancer using network pharmacology and experimental validation. First, we used a network pharmacology–based method to identify both the effective components of gypenosides and the molecular mechanism underlying their antibladder cancer effects. The results were further confirmed by molecular docking, CCK8 and colony formation assays, and cell cycle and cell apoptosis analyses. Additionally, a mouse xenograft model of bladder cancer was used to investigate the antitumor effect of gypenosides in vivo. We identified 10 bioactive ingredients and 163 gene targets of gypenosides. Network exploration suggested that VEGFA, STAT3, and PI3KCA may be candidate agents for the antibladder cancer effect of gypenosides. In addition, analysis of the Kyoto Encyclopedia of Genes and Genomes pathway revealed that the phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway may play a crucial role in the mechanism of action of gypenosides against bladder cancer. Molecular docking revealed that gypenosides combine well with PI3K, AKT, and mTOR. As expected, gypenosides displayed apoptosis-inducing properties in bladder cancer cells by inactivating the PI3K/AKT/mTOR signaling pathway in vitro. Furthermore, gypenosides significantly ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>P</mi> <mo><</mo> <mn>0.05</mn> </math> ) inhibited the growth of bladder cancer cells in vivo. Mechanistically, gypenosides induced the apoptosis of bladder cancer cells via inactivation of the PI3K/AKT/mTOR signaling pathway." @default.
- W4220808712 created "2022-04-03" @default.
- W4220808712 creator A5022868548 @default.
- W4220808712 creator A5023777271 @default.
- W4220808712 creator A5044301848 @default.
- W4220808712 creator A5044772105 @default.
- W4220808712 creator A5054313483 @default.
- W4220808712 creator A5056214905 @default.
- W4220808712 creator A5058814917 @default.
- W4220808712 creator A5080932332 @default.
- W4220808712 date "2022-03-29" @default.
- W4220808712 modified "2023-10-16" @default.
- W4220808712 title "Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer" @default.
- W4220808712 cites W1845652870 @default.
- W4220808712 cites W1906327883 @default.
- W4220808712 cites W2006771504 @default.
- W4220808712 cites W2007468670 @default.
- W4220808712 cites W2025527543 @default.
- W4220808712 cites W2028471200 @default.
- W4220808712 cites W2033459960 @default.
- W4220808712 cites W2034363193 @default.
- W4220808712 cites W2055864855 @default.
- W4220808712 cites W2108065093 @default.
- W4220808712 cites W2131371725 @default.
- W4220808712 cites W2144323242 @default.
- W4220808712 cites W2147837948 @default.
- W4220808712 cites W2166087001 @default.
- W4220808712 cites W2197072353 @default.
- W4220808712 cites W2253222212 @default.
- W4220808712 cites W2258857741 @default.
- W4220808712 cites W2287954036 @default.
- W4220808712 cites W2345071049 @default.
- W4220808712 cites W2473162054 @default.
- W4220808712 cites W2479754916 @default.
- W4220808712 cites W2525246130 @default.
- W4220808712 cites W2616936656 @default.
- W4220808712 cites W2724663598 @default.
- W4220808712 cites W2750320760 @default.
- W4220808712 cites W2765230239 @default.
- W4220808712 cites W2789045296 @default.
- W4220808712 cites W2789281724 @default.
- W4220808712 cites W2793422726 @default.
- W4220808712 cites W2836826811 @default.
- W4220808712 cites W2895833459 @default.
- W4220808712 cites W2896065754 @default.
- W4220808712 cites W2896751287 @default.
- W4220808712 cites W2905533588 @default.
- W4220808712 cites W2923057410 @default.
- W4220808712 cites W2936221437 @default.
- W4220808712 cites W2954137797 @default.
- W4220808712 cites W2980971679 @default.
- W4220808712 cites W2996145617 @default.
- W4220808712 cites W2998640129 @default.
- W4220808712 cites W2999417355 @default.
- W4220808712 cites W3023963569 @default.
- W4220808712 cites W3048201207 @default.
- W4220808712 cites W3102493364 @default.
- W4220808712 cites W3107934586 @default.
- W4220808712 cites W3127370626 @default.
- W4220808712 cites W569205627 @default.
- W4220808712 doi "https://doi.org/10.1155/2022/9304552" @default.
- W4220808712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35402614" @default.
- W4220808712 hasPublicationYear "2022" @default.
- W4220808712 type Work @default.
- W4220808712 citedByCount "10" @default.
- W4220808712 countsByYear W42208087122022 @default.
- W4220808712 countsByYear W42208087122023 @default.
- W4220808712 crossrefType "journal-article" @default.
- W4220808712 hasAuthorship W4220808712A5022868548 @default.
- W4220808712 hasAuthorship W4220808712A5023777271 @default.
- W4220808712 hasAuthorship W4220808712A5044301848 @default.
- W4220808712 hasAuthorship W4220808712A5044772105 @default.
- W4220808712 hasAuthorship W4220808712A5054313483 @default.
- W4220808712 hasAuthorship W4220808712A5056214905 @default.
- W4220808712 hasAuthorship W4220808712A5058814917 @default.
- W4220808712 hasAuthorship W4220808712A5080932332 @default.
- W4220808712 hasBestOaLocation W42208087121 @default.
- W4220808712 hasConcept C104317684 @default.
- W4220808712 hasConcept C121608353 @default.
- W4220808712 hasConcept C126322002 @default.
- W4220808712 hasConcept C150194340 @default.
- W4220808712 hasConcept C152724338 @default.
- W4220808712 hasConcept C162317418 @default.
- W4220808712 hasConcept C185592680 @default.
- W4220808712 hasConcept C190283241 @default.
- W4220808712 hasConcept C2778713507 @default.
- W4220808712 hasConcept C43617362 @default.
- W4220808712 hasConcept C4725764 @default.
- W4220808712 hasConcept C502942594 @default.
- W4220808712 hasConcept C526805850 @default.
- W4220808712 hasConcept C55493867 @default.
- W4220808712 hasConcept C71924100 @default.
- W4220808712 hasConcept C75217442 @default.
- W4220808712 hasConcept C86554907 @default.
- W4220808712 hasConcept C86803240 @default.
- W4220808712 hasConcept C96232424 @default.
- W4220808712 hasConcept C98274493 @default.
- W4220808712 hasConceptScore W4220808712C104317684 @default.